U.S. Sheds 23,000 Jobs in July; Weak Report Reshuffles Fed Rate Expectations Ahead of September Decision
The U.S. economy shed 23,000 jobs in July, far below the forecasted gain of 80,000, with prior months also revised downward by a combined 103,000 positions. The shock report has dramatically shifted market expectations, with odds of the Fed holding rates steady in September jumping from roughly 50-50 to 60-65%, upending previous expectations for a rate hike.
Israel Rejects Ceasefire Roadmap and Intensifies Gaza Strikes, Destroying Medicine Warehouses as Hamas Agrees to Disarmament Deal
Israel's Prime Minister Netanyahu rejected a U.S.-brokered ceasefire roadmap on July 30 that Hamas had agreed to, instead intensifying military operations in Gaza including strikes on medical infrastructure. The escalation killed 28 people over the weekend and destroyed two pharmaceutical warehouses serving al-Aqsa Martyrs Hospital, deepening an already severe humanitarian crisis as Gaza faces critical shortages of medicines and medical supplies.
Ukraine receives only one-third of promised air defense missiles as Russia intensifies strikes on Kyiv
Ukraine's President Zelenskyy revealed on August 5 that allied countries have delivered only one-third of the air defense missiles supplied in 2025, leaving the country unable to defend against Russia's escalating missile attacks. A massive Russian strike on Kyiv killed 17 people and wounded dozens, with Ukrainian air defenses failing to intercept any of the 24 ballistic missiles and 4 cruise missiles fired, highlighting the critical shortage of Patriot interceptors.
Fed Holds Rates Steady in 9-3 Vote as Three Members Dissent for Rate Hike
The Federal Reserve's policy committee voted 9-3 on July 29, 2026 to keep interest rates unchanged at 3.5%-3.75%, with dissenters Beth Hammack, Neel Kashkari, and Lorie Logan preferring a 25-basis-point increase. The divided vote reflects growing hawkish pressure over persistent inflation, which remains above the Fed's 2% target, while Chair Kevin Warsh stressed the committee's commitment to price stability and avoided providing forward guidance on future moves.
FDA approves three breakthrough treatments in 48 hours: mRNA flu vaccine, narcolepsy drug, and oncolytic virus therapy for melanoma
The FDA approved three first-in-class treatments within 48 hours in August 2026: mFlusiva, an mRNA flu vaccine up to 27% more effective than current shots; Orzeyful, the first drug targeting the root cause of narcolepsy type 1; and Tudriqev, an oncolytic virus therapy for treatment-resistant melanoma. Each represents a significant advance in different disease areas and regulatory pathways.
DOJ unseals charges against five CJNG leaders, offers over $100 million in rewards as cartel reorganizes after El Mencho's death
The U.S. Department of Justice on August 5, 2026, unsealed criminal charges against five senior leaders of the CJNG, Mexico's most powerful drug-trafficking organization, while the State Department raised total reward offers to over $100 million for information on eight CJNG fugitives. The action follows the February 2026 death of cartel leader El Mencho and comes as the Trump administration intensifies pressure on Mexican authorities to combat the organization.
Senate Committee votes to hold Fauci in contempt over Fifth Amendment invocations, refers to Justice Department
The Senate Homeland Security Committee voted 8-5 along party lines to hold Dr. Anthony Fauci in contempt of Congress for refusing to answer questions at a hearing, invoking the Fifth Amendment over 100 times. Committee Chair Rand Paul plans to refer the resolution directly to the Justice Department rather than hold a Senate floor vote, setting up a potential legal battle over the limits of Fauci's constitutional rights.
Senate passes Russia/Iran sanctions 86-11; Blanche AG confirmation cleared with Cassidy's pivotal vote
The Senate voted overwhelmingly Friday to pass sanctions legislation targeting Russian and Iranian energy sectors and leadership, renamed after the late Sen. Lindsey Graham. Separately, Sen. Bill Cassidy announced he will vote to confirm Todd Blanche as attorney general, providing the decisive vote needed for approval before the Senate's August recess.
Bioengineered chewing gum reduces HPV levels by 93% in lab study, offering potential head and neck cancer prevention tool
Researchers at the University of Pennsylvania developed a chewing gum made from lablab beans containing antiviral and antimicrobial compounds that reduced HPV levels by up to 93% in laboratory testing of oral samples from head and neck cancer patients. While promising as a low-cost, accessible approach that preserves beneficial bacteria unlike radiation therapy, the findings come from ex vivo testing and require human clinical trials to establish safety and real-world effectiveness.